Paras Healthcare Shares List at 3.9% Premium on NSE, BSE
Paras Healthcare Limited debuted on the stock market on October 28, 2026, following its ₹1,450 crore initial public offering (IPO). The shares listed at ₹720 apiece on both the NSE and BSE, a 3.9% premium over the issue price of ₹693 per share.
The IPO was subscribed 2.23 times during its three-day bidding period from October 21 to October 23, 2026.
Paras Healthcare IPO - Issue Details
- Issue Type: Book Built Issue (Fresh Issue + OFS)
- Total Issue Size: Up to ₹1,450.00 crore
- Fresh Issue: Up to ₹500.00 crore
- Offer for Sale (OFS): Up to ₹950.00 crore
- Face Value: ₹1 per equity share
- Price Band: ₹660 to ₹693 per share
- Lot Size: 21 shares
- Minimum Investment Amount (Retail Investor): ₹14,553 (21 shares at the upper price)
- Listing: BSE, NSE
- Book Running Lead Managers: JM Financial Limited, BofA Securities India Limited, Nuvama Wealth Management Limited
- Registrar: MUFG Intime India Private Limited
Explore other Upcoming IPOs on BSE and NSE.
Paras Healthcare IPO Overall Subscription Status
[October 23, 2026, 7:00 P.M.]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
3.09x |
|
Non-Institutional Investors (NIIs) |
0.66x |
|
Retail Individual Investors (RIIs) |
2.00x |
|
Employees |
23.61x |
|
Total |
2.23x |
Utilisation of IPO Proceeds
The company intends to utilise the net proceeds from the fresh issue towards:
- Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by the company
- Investment in its wholly owned Subsidiary, PMHPL (which also operates the company’s hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL
- General corporate purposes
About Paras Healthcare Limited
Established in 1987, Paras Healthcare Limited operates eight hospitals under the “Paras Health” brand, with a combined capacity of 2,211 beds across North India, Bihar and Jharkhand. As of June 30, 2026, its hospital network covered five states and one Union Territory.
The company plans to add 300 beds in Gurugram by Fiscal 2027 and another 500 beds in Ludhiana by Fiscal 2028, taking its total capacity to 3,011 beds by March 2028. Its major specialties include cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences, which together accounted for 74.70% of its revenue in Fiscal 2026. As of June 30, 2026, the company employed 1,084 doctors and 1,937 nurses.
Key Financial Highlights
|
Particulars |
For the three month period ended June 30, 2026 (in ₹ crore) |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
|
Revenue from operations |
470.28 |
1,605.95 |
1,294.06 |
|
EBITDA |
113.48 |
335.58 |
156.46 |
|
Profit After Tax (PAT) |
49.68 |
43.83 |
(57.98) |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here